Advanced Glycation End Product Cross‐Linking: Pathophysiologic Role and Therapeutic Target in Cardiovascular Disease
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Advanced glycation end products (AGEs) form by a nonenzymatic reaction between reducing sugars and biological proteins. These stable compounds accumulate slowly throughout the life span and contribute to structural and physiologic changes in the cardiovascular system such as increased vascular and myocardial stiffness, endothelial dysfunction, altered vascular injury responses, and atherosclerotic plaque formation. Mechanisms underlying these alterations include AGE cross‐linking of collagen and AGE interactions with circulating proteins and AGE receptors. The clinical manifestations of AGE accrual—isolated systolic hypertension, endothelial and diastolic dysfunction, and atherosclerosis—underscore their role in increased cardiovascular risk associated with aging as well as diabetes and hypertension, conditions that enhance AGE formation. New pharmacologic agents that prevent AGE, break cross‐links, or block AGE receptors reduce vascular and myocardial stiffness, inhibit atherosclerotic plaque formation, and improve endothelial function. These agents promise to reduce the risk of isolated systolic hypertension, diastolic dysfunction, and diabetes, and thus, heart failure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pulse pressure—a review of mechanisms and clinical relevance
Dart, A. M., & Kingwell, B. A. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01108-1 · Cited by 836
Cited by
Wang (2012) · doi:10.1161/circresaha.111.261388 · Cited by 957
“Each of the processes involved in atherogenesis and plaque rupture indicated as (1) to (6) are promoted by cellular senescence (illustration: Cosmocyte/Ben Smith).”
BackgroundAdvanced glycation endproducts in food and their effects on health
Poulsen, M. W., Hedegaard, R. V., Andersen, J. M., de Courten, B., Bügel, S., Nielsen, J., Skibsted, L. H., & Dragsted, L. O. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.06.052 · Cited by 751
Structural and Functional Remodeling of the Left Atrium
Casaclang-Verzosa, G., Gersh, B. J., & Tsang, T. S. M. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.09.026 · Cited by 529
Dietary Advanced Glycation End Products and Aging
Luevano-Contreras, C., & Chapman-Novakofski, K. (2010) · Nutrients · doi:10.3390/nu2121247 · Cited by 396
“Therefore, the accumulation of AGEs could be explained by some of the cardiovascular changes associated with aging, such as vascular stiffening, diastolic dysfunction and endothelial dysfunction [24].”
BackgroundPolyphenols with antiglycation activity and mechanisms of action: A review of recent findings
Yeh, W.-J., Hsia, S.-M., Lee, W.-H., & Wu, C.-H. (2017) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2016.10.017 · Cited by 353
Metadata
- Authors
- Zieman, S. J., & Kass, D. A.
- Venue
- Congestive Heart Failure
- Publisher
- Wiley
- Published
- 2004-05
- Volume
- 10
- Issue
- 3
- Pages
- 144-151
- ISSN
- 1527-5299 (ISSN-L)
- 1751-7133
- OpenAlex
- W2049233134
- Cited by
- 128
- References
- 1
- FWCI
- 1.44
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Advanced Glycation End Product Cross‐Linking: Pathophysiologic Role and Therapeutic Target in Cardiovascular Disease. https://app.cochat.ai/papers/10.1111/j.1527-5299.2004.03223.x
- The paper
- Zieman, S. J., & Kass, D. A. (2004). Advanced Glycation End Product Cross‐Linking: Pathophysiologic Role and Therapeutic Target in Cardiovascular Disease. Congestive Heart Failure. https://doi.org/10.1111/j.1527-5299.2004.03223.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.